Name:AITRL,MouseSynonyms:Activation-inducedTNFRmemberLigand,TNFSF18,GITRL,TL-6Description:Activation-InducibleTNF-RelatedLigand(AITRL),alsoknownasGlucocorticoid-InducedTNF-RelatedLigand(GITRL),belongstothetumornecrosisfactorsuperfamily(TNFSF).AITRLisaTypeIIsingletransmembraneproteinandshareslowconservationwithintheextracellulardomainwithotherTNFSFmembers.AITRLisexpressedonmacrophages,immatureandmaturedendriticcellsandBcells.Itsreceptor,Activation-InducibleTNFRfamilyReceptor(AITR),isexpressedonTlymphocytes,naturalkiller(NK)cells,andantigen-presentingcells.AfterbindingbyAITRL,AITRcanbereleased.AITRactivationincreasesresistancetotumorsandviralinfectionsandisinvolvedinautoimmuneandinflammatoryprocesses.Inaddition,activatedAITRincreasesTCR-inducedTcellproliferationandcytokineproductionandrescuesTcellsandNKcellsfromapoptosis.RecombinantmouseActivation-InducibleTNF-RelatedLigand(rmAITRL)producedinE.通过研究,CDNF可防止6-羟基多巴胺(6-OHDA)诱导的多巴胺能神经元变性,这可能对帕金森氏病有益。Recombinant Rat CINC-1/CXCL1
Recombinant Biotinylated Human KIR2DL1 Protein,His-Avi Tag性能参数分子别名(Synonyms)CD158A;CD158Ankat1;cl-42表达区间及表达系统(Source)BiotinylatedHumanKIR2DL1ProteinisexpressedfromHEK293withHistagandAvitagattheC-Terminus.ItcontainsHis22-Arg242.[Accession|P43626]分子量大小(MolecularWeight)TheproteinhasapredictedMWof27.1kDa.Duetoglycosylation,theproteinmigratesto48-60kDabasedonSDS-PAGEresult.(Endotoxin)Lessthan1EUperμgbytheLALmethod.纯度(Purity)>95%asdeterminedbySDS-PAGEandHPLC.制剂(Formulation)Lyophilizedfrom0.22μmfilteredsolutioninPBS(pH7.4).Normally8%trehaloseisaddedasprotectantbeforelyophilization.重构方法(Reconstitution)Centrifugethetubebeforeopening.Reconstitutingtoaconcentrationmorethan100μg/mlisrecommended.Dissolvethelyophilizedproteinindistilledwater.储存条件Theproductshouldbestoredat-25~-15℃for1yearfromdateofreceipt.2-7days,2~8°Cundersterileconditionsafterreconstitution.Recombinant Mouse SLAMF7/CRACC/CD319 Protein,His TagSUMO蛋白酶识别完整的含有100个氨基酸的SUMO标签蛋白,并能高效地把SUMO从融合蛋白上切割下来。
Recombinant Biotinylated Human MSLN/Mesothelin Protein,hFc-Avi Tag分子别名(Synonyms)Mesothelin;CAK1;MSLN;MPFSMRP表达区间及表达系统(Source)BiotinylatedHumanMSLN/MesothelinProteinisexpressedfromHEK293withhFctagandAvitagattheC-Terminus.ItcontainsGlu296-Gly580.[Accession|Q13421-2]分子量大小(MolecularWeight)TheproteinhasapredictedMWof61.1kDa.Duetoglycosylation,theproteinmigratesto70-80kDabasedonSDS-PAGEresult.(Endotoxin)Lessthan1EUperμgbytheLALmethod.纯度(Purity)>95%asdeterminedbySDS-PAGEandHPLC.活性(Activity)ELISAData:ImmobilizedAnti-MSLNAntibody,hFcTagat1μg/ml(100μl/well)ontheplate.DoseresponsecurveforBiotinylatedHumanMSLN,hFcTagwiththeEC50of18.4ng/mldeterminedbyELISA.
Trop-2,alsoknownasepithelialglycoprotein-1antigen(EGP-1),isaproteinthatinhumansisencodedbytheTACSTD2gene.Mutationsofthisgeneresultingelatinousdrop-likecornealdystrophy,anautosomalrecessivedisordercharacterizedbyseverecornealamyloidosisleadingtoblindness.产品性质别名EGP1;EGP-1;TROP2;GA733-1;gp50;T16;TACSTD2;TROP-2;M1S1;TACD2UniprotNo.P09758表达区间及表达系统RecombinantBiotinylatedHumanTROP-2/TACSTD2ProteinisexpressedfromHEK293cellswithHistagandAvitagattheC-terminal.ItcontainsHis27-Thr274.分子量TheproteinhasapredictedMWof30.5kDa.Duetoglycosylation,theproteinmigratesto46-55kDabasedonTris-BisPAGEresult.纯度>95%asdeterminedbySDS-PAGEandHPLC活性ELISAData:ImmobilizedAnti-TROP-2Antibody,hFcTagat0.5μg/mL(100μL/well)ontheplate.DoseresponsecurveforBiotinylatedHumanTROP-2,HisTagwiththeEC50of24.1ng/mLdeterminedbyELISA.0EUper1μgoftheproteinbytheLALmethod.制剂Lyophilizedfrom0.22μmfilteredsolutioninPBS(pH7.4).Normally5%trehaloseisaddedasprotectantbeforelyophilization.泛素化反应可以修饰蛋白质,调节蛋白质降解。泛素化还影响蛋白质体事件,如蛋白质定位、活性和功能。
Enterokinase,Recombinant,Expressed in E.coli大肠杆菌表达重组肠激酶(不带标签)注意事项1.本产品所讲述的缓冲体系需要自行配置。2.不建议37℃条件下酶切,可能会有非特异性酶切出现。3.在>200mM咪唑,或>200mMNaCl,或>5%甘油,酶切会受到影响。如果样品溶液中含有上述成分的一种或多种,为获得理想的酶切结果,请先将样品透析到25mMTris-HCl8.0缓冲液中,然后再进行酶切实验;若不方便透析,可将样品稀释到咪唑含量在100mM以下,NaCl浓度在50mM以下,甘油浓度小于5%以下进行酶切,酶的用量与蛋白比例不变;若干扰因素很多,且不便去除,需要适当增加酶量或延长酶切时间,有助于得到理想的酶切效果。4.磷酸盐对Enterokinase有很强的抑制作用,痕量的磷酸盐都会严重影响Enterokinase的活性,因此在酶切体系内不能存在磷酸盐。5.本品是具有高酶活力重组肠激酶,切割蛋白使用量少,可不考虑除去。后续如需去除重组肠激酶,可用阴离子交换树脂(如DEAE-FF)对其进行洗脱。推荐洗脱条件如下:平衡缓冲液:25mMTris-HClpH8.0洗脱缓冲液:25mMTris-HClpH8.0,含100mMNaCl6.蛋白酶切效果不好,可适当增加酶量,或适当延长酶切时间。SDF-1同工型与细胞表面上的CXCR4和CXCR7受体相互作用,也可以结合Syndecan-4。Recombinant Human NKG2A/CD159a Protein,His-Avi Tag
在体内,活化的X因子(Factor Xa)切割凝血酶原,释放出活性肽并将凝血酶切割成具有催化活性的α-凝血酶。Recombinant Rat CINC-1/CXCL1
PE-labeled Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Tetramer Protein,His-Avi Tag性能参数表达区间及表达系统(Source)PE-labeledHumanHLA-A*02:01&B2M&P53R175H(HMTEVVRHC)TetramerProteinisexpressedfromHEK293withHistagandAvitagattheC-Terminus.PE-labeledHumanHLA-A*02:01&B2M&P53R175H(HMTEVVRHC)TetramerisassembledbybiotinylatedmonomerandPE-labeledstreptavidin.ItcontainsGly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)andHMTEVVRHCpeptide.(Endotoxin)Lessthan1EUperμgbytheLALmethod.制剂(Formulation)Suppliedas0.22μmfilteredsolutionin20mMPB,500mMNaCl,0.2%BSA(pH8.0).储存条件Theproductshouldbestoredat-85~-65℃for3monthfromdateofreceipt.Recommendtoaliquottheproteinintosmallerquantitieswhenfirstusedandavoidrepeatedfreeze-thawcycles.Recombinant Rat CINC-1/CXCL1
磁珠法在基因克隆中的应用主要体现在以下几个方面:1.**质粒DNA的提取**:磁珠法可以用于从细菌细胞中提取质粒DNA,这对于质粒的克隆和表达至关重要。通过磁珠法提取的质粒DNA纯度高,适合用于后续的酶切、连接、转化等分子克隆步骤。2.**基因组DNA的提取**:磁珠法可以用于从各种生物样本中提取基因组DNA,这对于基因组的克隆和分析非常重要。提取的基因组DNA可以用于PCR扩增、基因表达分析、基因突变检测等。3.**mRNA的提取和纯化**:在mRNA克隆中,磁珠法可以用于提取和纯化mRNA,这对于cDNA的合成和基因表达分析非常关键。磁珠法提取的mRNA纯度高,可以用于后续的cDNA合成和...